TY - JOUR
T1 - Emerging Techniques in Cardiac Magnetic Resonance Imaging
AU - Guo, Rui
AU - Weingärtner, Sebastian
AU - Šiurytė, Paulina
AU - T. Stoeck, Christian
AU - Füetterer, Maximilian
AU - E. Campbell-Washburn, Adrienne
AU - Suinesiaputra, Avan
AU - Jerosch-Herold, Michael
AU - Nezafat, Reza
N1 - Publisher Copyright:
© 2021 International Society for Magnetic Resonance in Medicine
PY - 2022/4
Y1 - 2022/4
N2 - Cardiovascular disease is the leading cause of death and a significant contributor of health care costs. Noninvasive imaging plays an essential role in the management of patients with cardiovascular disease. Cardiac magnetic resonance (MR) can noninvasively assess heart and vascular abnormalities, including biventricular structure/function, blood hemodynamics, myocardial tissue composition, microstructure, perfusion, metabolism, coronary microvascular function, and aortic distensibility/stiffness. Its ability to characterize myocardial tissue composition is unique among alternative imaging modalities in cardiovascular disease. Significant growth in cardiac MR utilization, particularly in Europe in the last decade, has laid the necessary clinical groundwork to position cardiac MR as an important imaging modality in the workup of patients with cardiovascular disease. Although lack of availability, limited training, physician hesitation, and reimbursement issues have hampered widespread clinical adoption of cardiac MR in the United States, growing clinical evidence will ultimately overcome these challenges. Advances in cardiac MR techniques, particularly faster image acquisition, quantitative myocardial tissue characterization, and image analysis have been critical to its growth. In this review article, we discuss recent advances in established and emerging cardiac MR techniques that are expected to strengthen its capability in managing patients with cardiovascular disease. Level of Evidence: 5. Technical Efficacy: Stage 1.
AB - Cardiovascular disease is the leading cause of death and a significant contributor of health care costs. Noninvasive imaging plays an essential role in the management of patients with cardiovascular disease. Cardiac magnetic resonance (MR) can noninvasively assess heart and vascular abnormalities, including biventricular structure/function, blood hemodynamics, myocardial tissue composition, microstructure, perfusion, metabolism, coronary microvascular function, and aortic distensibility/stiffness. Its ability to characterize myocardial tissue composition is unique among alternative imaging modalities in cardiovascular disease. Significant growth in cardiac MR utilization, particularly in Europe in the last decade, has laid the necessary clinical groundwork to position cardiac MR as an important imaging modality in the workup of patients with cardiovascular disease. Although lack of availability, limited training, physician hesitation, and reimbursement issues have hampered widespread clinical adoption of cardiac MR in the United States, growing clinical evidence will ultimately overcome these challenges. Advances in cardiac MR techniques, particularly faster image acquisition, quantitative myocardial tissue characterization, and image analysis have been critical to its growth. In this review article, we discuss recent advances in established and emerging cardiac MR techniques that are expected to strengthen its capability in managing patients with cardiovascular disease. Level of Evidence: 5. Technical Efficacy: Stage 1.
KW - cardiac magnetic resonance
KW - deep learning
KW - low-field imaging
KW - machine learning
KW - myocardial tissue characterization
KW - radiomics
UR - http://www.scopus.com/inward/record.url?scp=85111664399&partnerID=8YFLogxK
U2 - 10.1002/jmri.27848
DO - 10.1002/jmri.27848
M3 - Review article
C2 - 34331487
AN - SCOPUS:85111664399
SN - 1053-1807
VL - 55
SP - 1043
EP - 1059
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 4
ER -